Literature DB >> 25087568

Retinoic acid regulates cell cycle genes and accelerates normal mouse liver regeneration.

Hui-Xin Liu1, Irene Ly2, Ying Hu3, Yu-Jui Yvonne Wan4.   

Abstract

All-trans retinoic acid (RA) is a potent inducer of regeneration. Because the liver is the principal site for storage and bioactivation of vitamin A, the current study examines the effect of RA in mouse hepatocyte proliferation and liver regeneration. Mice that received a single dose of RA (25μg/g) by oral gavage developed hepatomegaly with increased number of Ki67-positive cells and induced expression of cell cycle genes in the liver. DNA binding data revealed that RA receptors retinoic acid receptor β (RARβ) and retinoid x receptor α (RXRα) bound to cell cycle genes Cdk1, Cdk2, Cyclin B, Cyclin E, and Cdc25a in mice with and without RA treatment. In addition, RA treatment induced novel binding of RARβ/RXRα to Cdk1, Cdk2, Cyclin D, and Cdk6 genes. All RARβ/RXRα binding sites contained AGGTCA-like motifs. RA treatment also promoted liver regeneration after partial hepatectomy (PH). RA signaling was implicated in normal liver regeneration as the mRNA levels of RARβ, Aldh1a2, Crabp1, and Crbp1 were all induced 1.5 days after PH during the active phase of hepatocyte proliferation. RA treatment prior to PH resulted in early up-regulation of RARβ, Aldh1a2, Crabp1, and Crbp1, which was accompanied by an early induction of cell cycle genes. Western blotting for RARβ, c-myc, Cyclin D, E, and A further supported the early induction of retinoid signal and cell proliferation by RA treatment. Taken together, our data suggest that RA may regulate cell cycle progression and accelerates liver regeneration. Such effect is associated with an early induction of RA signaling, which includes increased expression of the receptor, binding proteins, and processing enzyme for retinoids. Published by Elsevier Inc.

Entities:  

Keywords:  Hepatocyte; Nuclear receptor; Partial hepatectomy; Proliferation; Pubchem CID: 444795; Retinoic acid receptor

Mesh:

Substances:

Year:  2014        PMID: 25087568      PMCID: PMC4236911          DOI: 10.1016/j.bcp.2014.07.003

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  55 in total

Review 1.  Retinoid pathway and cancer therapeutics.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  Adv Drug Deliv Rev       Date:  2010-08-03       Impact factor: 15.470

2.  The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration.

Authors:  Xinhe Wang; Hiroaki Kiyokawa; Margaret B Dennewitz; Robert H Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

Review 3.  The promise of retinoids to fight against cancer.

Authors:  L Altucci; H Gronemeyer
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

Review 4.  All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

Authors:  L Degos; H Dombret; C Chomienne; M T Daniel; J M Micléa; C Chastang; S Castaigne; P Fenaux
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

5.  Involvement of retinoic acid-induced transglutaminase activity in zonal differences of hepatocyte proliferation after partial hepatectomy.

Authors:  Yosuke Ohtake; Akiko Maruko; Shinya Abe; Tomomi Nagashima; Manabu Fukumoto; Yasuhito Ohkubo
Journal:  J Gastroenterol Hepatol       Date:  2006-11       Impact factor: 4.029

6.  Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.

Authors:  S Eva Singletary; Edward N Atkinson; Ashraful Hoque; Nour Sneige; Ayse A Sahin; Herbert A Fritsche; Reuben Lotan; Tao Lu; Walter N Hittelman; Therese B Bevers; Carol B Stelling; Scott M Lippman
Journal:  Clin Cancer Res       Date:  2002-09       Impact factor: 12.531

7.  Effect of retinoic acid on transglutaminase and ornithine decarboxylase activities during liver regeneration.

Authors:  Yosuke Ohtake; Akiko Maruko; Nao Ohishi; Masasumi Kawaguchi; Tetsuharu Satoh; Yasuhito Ohkubo
Journal:  Cell Biochem Funct       Date:  2008-04       Impact factor: 3.685

Review 8.  Retinoic acid, a regeneration-inducing molecule.

Authors:  Malcolm Maden; Matthew Hind
Journal:  Dev Dyn       Date:  2003-02       Impact factor: 3.780

9.  Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial.

Authors:  Matteo Dalla Chiesa; Rodolfo Passalacqua; Maria Michiara; Vittorio Franciosi; Francesco Di Costanzo; Giancarlo Bisagni; Roberta Camisa; Sebastiano Buti; Gianluca Tomasello; Giorgio Cocconi
Journal:  Acta Biomed       Date:  2007-12

10.  Cellular retinoid-binding proteins in reginerating rat liver: demonstration of a novel cellular retinoid-binding protein.

Authors:  M Omori; Y Muto; T Nagao
Journal:  J Lipid Res       Date:  1981-08       Impact factor: 5.922

View more
  24 in total

1.  Analysis of vitamin A and retinoids in biological matrices.

Authors:  Lindsay C Czuba; Guo Zhong; King C Yabut; Nina Isoherranen
Journal:  Methods Enzymol       Date:  2020-03-26       Impact factor: 1.600

2.  Retinoic acid and microRNA.

Authors:  Lijun Wang; Atharva Piyush Rohatgi; Yu-Jui Yvonne Wan
Journal:  Methods Enzymol       Date:  2020-03-28       Impact factor: 1.600

3.  Enhancement of tumor suppressor RAR-β protein expression by cationic liposomal-ATRA treatment in benzo(a)pyrene-induced lung cancer mice model.

Authors:  S Viswanathan; V M Berlin Grace; J Perinba Danisha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-12       Impact factor: 3.000

4.  Molecular characterization and gene expression patterns of retinoid receptors, in normal and regenerating tissues of the sea cucumber, Holothuria glaberrima.

Authors:  Jorge Viera-Vera; José E García-Arrarás
Journal:  Gene       Date:  2018-02-07       Impact factor: 3.688

5.  Retinoic acid promotes primary fetal alveolar epithelial type II cell proliferation and differentiation to alveolar epithelial type I cells.

Authors:  Rui-wei Gao; Xiang-yong Kong; Xiao-xi Zhu; Guo-qing Zhu; Jin-shuai Ma; Xiu-xiang Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-17       Impact factor: 2.416

Review 6.  Targeting fatty acid metabolism for fibrotic disorders.

Authors:  Seonghwan Hwang; Ki Wung Chung
Journal:  Arch Pharm Res       Date:  2021-10-18       Impact factor: 4.946

Review 7.  Implications of microbiota and bile acid in liver injury and regeneration.

Authors:  Hui-Xin Liu; Ryan Keane; Lili Sheng; Yu-Jui Yvonne Wan
Journal:  J Hepatol       Date:  2015-08-07       Impact factor: 25.083

8.  Functional analysis of the relationship between intestinal microbiota and the expression of hepatic genes and pathways during the course of liver regeneration.

Authors:  Hui-Xin Liu; Clarissa Santos Rocha; Satya Dandekar; Yu-Jui Yvonne Wan
Journal:  J Hepatol       Date:  2016-01-12       Impact factor: 25.083

9.  GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells.

Authors:  Shan-Ling Liu; Zhen Liu; Li-Di Zhang; Han-Qing Zhu; Jia-Hui Guo; Mei Zhao; Ying-Li Wu; Feng Liu; Feng-Hou Gao
Journal:  Cell Cycle       Date:  2017-11-14       Impact factor: 4.534

Review 10.  Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair.

Authors:  Suya Wang; Jianshi Yu; Maureen A Kane; Alexander R Moise
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.